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Gene expression patterns using microarray analysis in MCF-7 cells showed
that the histone acetylase 6 (HDAC6) gene was one of the early-responsive
oestrogen-induced genes (J Mol Endocrinol 2002, 29). This led us to
hypothesise that there was a link between levels of HDAC6 expression and
the hormone-dependent potential of breast cancer. In the present study, the
level of HDAC6 mRNA expression was analysed using quantitative real-time
reverse transcriptase-polymerase chain reaction (RT-PCR) in 158 patients
withinvasive breast cancer and the protein expressions were also determined by
immunohistochemistry. HDAC6 mRNA was expressed at signiﬁcantly higher
levels in breast cancer patients with small tumours measuring less than 2 cm,
without a high histological tumour grade, and in oestrogen receptor (ER) a- and
progesterone receptor (PgR)-positive tumours. Patients expressing high levels of
HDAC6 mRNA have a statistically better prognosis than those expressing low
levels. Furthermore, the patients with high levels of HDAC6 mRNA tended to
be more responsive to endocrine treatments than those with low levels. Speciﬁc
staining was found in the nucleus of some normal epithelial cells and in the
cytoplasm of most of the cancer cells. However, no relationship was found
between HDAC6 cytoplasmic expression and any clinicopathological factors or
survival. We conclude that the expression levels of HDAC6 mRNA could have
potential as a prognostic and predictive marker for endocrine treatment in breast
cancer.
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